Philips and Mass General Brigham announce collaboration to improve patient care with live AI-powered insights
Philips (NYSE: PHG) and Mass General Brigham (MGB) announced a collaboration to develop and deploy advanced data infrastructure and AI for improving patient care. The partnership aims to create a unified, near real-time data and insights ecosystem by integrating live healthcare data from multiple sources.
The collaboration will utilize Philips technologies including Capsule Medical Device Information Platform, Clinical Insights Manager, and Capsule Surveillance to combine data from bedside medical devices with longitudinal clinical data. The system will enable continuous algorithmic processing to deliver smart alerts into live clinical practice.
An initial research program focuses on patients under continuous heart monitoring, aiming to improve early detection of cardiac events. The joint effort combines MGB's biomedical engineering, clinical specialists, and AI expertise with Philips' research capabilities to develop new algorithms for identifying patient-cohort patterns and generating actionable clinical insights.
Philips (NYSE: PHG) e Mass General Brigham (MGB) hanno annunciato una collaborazione per sviluppare e implementare un'infrastruttura dati avanzata e l'IA per migliorare l'assistenza ai pazienti. L'obiettivo della partnership è creare un ecosistema di dati e informazioni unificato e quasi in tempo reale integrando dati sanitari in tempo reale provenienti da più fonti.
La collaborazione utilizzerà le tecnologie Philips, tra cui la Capsule Medical Device Information Platform, il Clinical Insights Manager e Capsule Surveillance, per combinare i dati dai dispositivi medici vicino al letto del paziente con i dati clinici longitudinali. Il sistema consentirà un'elaborazione algoritmica continua per fornire avvisi intelligenti nella pratica clinica in tempo reale.
Un programma di ricerca iniziale si concentra sui pazienti sottoposti a monitoraggio cardiaco continuo, con l'obiettivo di migliorare la rilevazione precoce degli eventi cardiaci. Lo sforzo congiunto combina l'ingegneria biomedica, gli specialisti clinici e l'expertise in IA di MGB con le capacità di ricerca di Philips per sviluppare nuovi algoritmi per identificare i modelli di coorte dei pazienti e generare informazioni cliniche utili.
Philips (NYSE: PHG) y Mass General Brigham (MGB) anunciaron una colaboración para desarrollar e implementar una infraestructura de datos avanzada y IA para mejorar la atención al paciente. La asociación tiene como objetivo crear un ecosistema unificado de datos e información casi en tiempo real al integrar datos de salud en vivo de múltiples fuentes.
La colaboración utilizará tecnologías de Philips, incluyendo la Capsule Medical Device Information Platform, el Clinical Insights Manager y Capsule Surveillance, para combinar datos de dispositivos médicos junto a la cama con datos clínicos longitudinales. El sistema permitirá un procesamiento algorítmico continuo para ofrecer alertas inteligentes en la práctica clínica en vivo.
Un programa de investigación inicial se centra en pacientes bajo monitoreo cardíaco continuo, con el objetivo de mejorar la detección temprana de eventos cardíacos. El esfuerzo conjunto combina la ingeniería biomédica, especialistas clínicos y experiencia en IA de MGB con las capacidades de investigación de Philips para desarrollar nuevos algoritmos que identifiquen patrones de cohortes de pacientes y generen información clínica útil.
필립스 (NYSE: PHG)와 매스 제너럴 브라임(MGB)은 환자 치료 개선을 위한 고급 데이터 인프라와 AI를 개발하고 배포하기 위해 협력한다고 발표했습니다. 이 파트너십의 목표는 여러 출처의 실시간 의료 데이터를 통합하여 통합된 거의 실시간 데이터 및 인사이트 생태계를 만드는 것입니다.
이 협력은 침대 옆 의료기기로부터의 데이터와 장기적인 임상 데이터를 결합하기 위해 Capsule Medical Device Information Platform, Clinical Insights Manager 및 Capsule Surveillance을 포함한 필립스 기술을 활용합니다. 이 시스템은 실시간 임상 실습에 스마트 알림을 제공하기 위해 지속적인 알고리즘 처리를 가능하게 합니다.
초기 연구 프로그램은 지속적인 심장 모니터링을 받는 환자에 중점을 두고 있으며, 심장 사건의 조기 감지를 개선하는 것을 목표로 합니다. 이 공동 노력은 MGB의 생물 의공학, 임상 전문가 및 AI 전문 지식과 필립스의 연구 능력을 결합하여 환자 집단 패턴을 식별하고 실행 가능한 임상 인사이트를 생성하기 위한 새로운 알고리즘을 개발합니다.
Philips (NYSE: PHG) et Mass General Brigham (MGB) ont annoncé une collaboration pour développer et déployer une infrastructure de données avancée et de l'IA afin d'améliorer les soins aux patients. L'objectif du partenariat est de créer un écosystème unifié de données et d'informations presque en temps réel en intégrant des données de santé en direct provenant de plusieurs sources.
La collaboration utilisera les technologies Philips, y compris la Capsule Medical Device Information Platform, le Clinical Insights Manager et Capsule Surveillance, pour combiner les données des dispositifs médicaux au chevet des patients avec des données cliniques longitudinales. Le système permettra un traitement algorithmique continu pour fournir des alertes intelligentes dans la pratique clinique en direct.
Un programme de recherche initial se concentre sur les patients sous surveillance cardiaque continue, visant à améliorer la détection précoce des événements cardiaques. Cet effort conjoint combine l'ingénierie biomédicale, les spécialistes cliniques et l'expertise en IA de MGB avec les capacités de recherche de Philips pour développer de nouveaux algorithmes permettant d'identifier les modèles de cohortes de patients et de générer des informations cliniques exploitables.
Philips (NYSE: PHG) und Mass General Brigham (MGB) haben eine Zusammenarbeit angekündigt, um eine fortschrittliche Dateninfrastruktur und KI zur Verbesserung der Patientenversorgung zu entwickeln und einzusetzen. Das Ziel der Partnerschaft ist es, ein einheitliches, nahezu Echtzeit-Daten- und Erkenntnisökosystem zu schaffen, indem Live-Gesundheitsdaten aus mehreren Quellen integriert werden.
Die Zusammenarbeit wird Philips-Technologien nutzen, darunter die Capsule Medical Device Information Platform, den Clinical Insights Manager und Capsule Surveillance, um Daten von medizinischen Geräten am Bett des Patienten mit longitudinalen klinischen Daten zu kombinieren. Das System ermöglicht eine kontinuierliche algorithmische Verarbeitung, um intelligente Warnungen in die klinische Praxis zu liefern.
Ein erstes Forschungsprogramm konzentriert sich auf Patienten, die kontinuierlich am Herzen überwacht werden, mit dem Ziel, die frühzeitige Erkennung von Herzereignissen zu verbessern. Die gemeinsame Anstrengung kombiniert die biomedizinische Ingenieurwissenschaft, klinische Spezialisten und KI-Expertise von MGB mit den Forschungsfähigkeiten von Philips, um neue Algorithmen zu entwickeln, die Muster von Patientenkohorten identifizieren und umsetzbare klinische Erkenntnisse generieren.
- Development of real-time data analytics system for improved patient care
- Strategic partnership with major US hospital system Mass General Brigham
- Integration of multiple Philips technology platforms for comprehensive healthcare data analysis
- Potential for new revenue streams through AI-powered healthcare solutions
- None.
Insights
This strategic collaboration between Philips and Mass General Brigham (MGB) represents a significant pivot in Philips' business model, moving beyond traditional medical device manufacturing into high-margin, recurring revenue streams through AI-powered software solutions. The partnership with MGB, one of the most prestigious healthcare institutions in the US, provides Philips with valuable clinical validation and real-world testing environments that could accelerate market adoption.
The integration of Philips' Capsule Medical Device Information Platform with real-time clinical data creates a powerful technological moat. By establishing early partnerships and developing proprietary algorithms, Philips is positioning itself ahead of competitors in the rapidly growing healthcare AI market, estimated to reach
Three key aspects make this collaboration particularly valuable for investors:
- The focus on creating a unified data ecosystem addresses a critical pain point in healthcare, potentially leading to widespread adoption across other hospital systems
- The development of predictive analytics and smart alerts creates recurring revenue opportunities through software licensing and subscriptions
- The partnership model with MGB provides a blueprint for scaling similar implementations across other healthcare institutions, potentially accelerating market penetration
The initial focus on cardiac monitoring is strategically sound, as it represents a high-value use case with clear clinical and economic benefits. Success in this area could lead to rapid expansion into other clinical domains, creating multiple revenue streams from both software licensing and data analytics services.
February 21, 2025
Integrating advanced data analytics into clinical practice to improve patient care
Amsterdam, The Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Mass General Brigham (MGB), home to one of the largest hospital system-based research enterprises in the US, today announced a new collaboration to develop and deploy advanced data infrastructure and AI designed to integrate and process live healthcare data from a wide range of sources to improve patient care.
Today, healthcare providers often rely on disparate data sources, including static Electronic Medical Record (EMR) data, clinical notes, and isolated device alarms. By streaming accurate, reliable and detailed data from medical devices and other sources, Philips and MGB aim to create a scalable, unified, near real-time data and insights ecosystem. Powered by Philips software platforms, the collaboration aims to enable clinicians to capture, analyze, and react to data as it is available, potentially improving the effectiveness and efficiency of patient care.
"This exciting collaboration marks a key step forward in healthcare innovation, harnessing the full potential of AI and medical device data to advance patient safety, operational efficiency, clinician ergonomics, while opening new discovery possibilities,” said Dr. Tom McCoy, Medical Director of Biomedical Engineering at Massachusetts General Hospital. “By mobilizing previously siloed medical device data into an integrated high speed, high resiliency, real time data fabric we will be able to deliver the transformative potential of software to the patients who need it most."
The collaboration will leverage a combination of Philips technologies to unify active data streaming from medical devices at the bedside, such as ventilators and monitors, with other longitudinal clinical data, such as lab results and EMR data, to create a comprehensive and actionable data environment. Philips Capsule Medical Device Information Platform brings together data from different devices, allowing Philips Clinical Insights Manager to facilitate retrospective analysis and testing, and Philips Capsule Surveillance to leverage continuous algorithmic processing to deliver smart alerts into live clinical practice.
For the collaboration, Mass General Brigham is bringing together the expertise of its biomedical engineering team, clinical sub-specialists, digital teams and internal AI business unit (Mass General Brigham AI) with Philips’ research and business teams. The joint effort will deliver data insights, enhance data integration and foster the development of new algorithms, capable of identifying patient-cohort patterns and generating smart alerts for clinical intervention. These alerts will provide clinicians with actionable insights at critical moments to support better patient care.
An initial research program as part of the collaboration focuses on patients undergoing continuous, real-time heart monitoring. By analyzing this data, the research aims to improve early detection of cardiac events and other critical health issues, potentially saving lives and expediting treatment.
“This collaboration between Philips and Mass General Brigham represents a significant step forward in the integration of advanced data analytics into clinical practice,” said Betsabeh Madani Hermann, Global Head of Research at Philips. “By developing predictive data analytics and AI algorithms, key tools for enhancing patient care, we’re empowering clinicians and supporting better care for more people.”
For further information, please contact:
Anna Hogrebe
Philips Global External Relations
Tel.: +1 416 270 6757
E-Mail: anna.hogrebe@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachments
FAQ
What is the purpose of Philips (PHG) collaboration with Mass General Brigham?
Which Philips (PHG) technologies are being used in the Mass General Brigham partnership?
What is the initial research focus of the Philips-MGB collaboration?
How will the Philips (PHG) AI system benefit healthcare providers?
What types of data will the Philips-MGB collaboration analyze?
